London's FTSE 100 steadies after four-day slide; inflation data boosts rate cut bets

London's FTSE 100 was essentially flat after four straight sessions of losses, down 0.07% mid-session while the FTSE 250 ticked up 0.07%, as an October slowdown in UK inflation lifted odds of a Bank of England rate cut in December (markets pricing ~86%) and a Reuters poll showed most economists now expect cuts in December and early next year. Defensive consumer staples and healthcare names helped anchor the market—Unilever and British American Tobacco each rose about 1%, AstraZeneca was up 0.8% and the pharma sector gained 0.5%—while precious metal miners jumped 4.7% as gold climbed, industrial metal miners rose modestly and banking stocks fell 0.4% in a fifth consecutive decline. Aerospace and defence underperformed (down ~2% with BAE -2.6% and Rolls-Royce -0.8%), household goods and construction fell, UK house-price inflation slowed to its weakest annual rise since May, and individual movers included WH Smith (+5.2%) after CEO Carl Cowling stepped down amid an independent review into U.S. accounting failures and Sage (+3.3%) after stronger-than-expected annual operating profit.

Analysis

London's FTSE 100 was essentially flat mid-session, down 0.07% at 12:40 GMT after four straight sessions of losses while the FTSE 250 edged up 0.07%, with defensive consumer staples and healthcare providing support—Unilever and British American Tobacco each rose about 1%, AstraZeneca was up 0.8% and the broader pharma sector advanced 0.5%. Precious metal miners jumped 4.7% as gold climbed over 1% on risk aversion ahead of key U.S. data, and industrial metal miners rose 0.3%, offsetting weakness elsewhere.

UK inflation slowed in October for the first time since May, driving markets to price roughly an 86% chance of a quarter-point Bank of England cut in December; a Reuters poll showed a majority of economists expect cuts in December and again early next year, and market commentary flagged the Autumn Budget as a potential catalyst for MPC action. Matthew Ryan noted a tax-heavy budget would increase the likelihood of a December cut, implying a dovish policy backdrop into year-end.

Sector divergence is pronounced: banking stocks fell 0.4% and are on track for a fifth consecutive decline, aerospace and defence dropped about 2% with BAE down 2.6% and Rolls-Royce 0.8%, and household goods and construction slipped 0.7%; UK house prices showed the smallest annual rise in September since May. Corporate idiosyncratic moves included WH Smith +5.2% after its CEO stepped down following an independent review revealing U.S. accounting failures (heightened governance risk) and Sage +3.3% after better-than-expected annual operating profit.

Key Decisions for Investors

• Consider modestly overweighting defensive consumer staples and large-cap pharma in UK equity allocations to capture near-term support if December rate-cut expectations materialize
• Reduce or hedge exposure to UK banks and other rate-sensitive financials given a fifth consecutive session of declines and the heightened probability of BoE easing that could pressure net interest margins
• Monitor the Autumn Budget details and subsequent BoE communications and UK inflation prints as primary catalysts that could rapidly reprice cyclicals,
• Avoid adding material exposure to WH Smith until U.S. accounting issues are resolved and treat Sage as a validated near-term outperformer based on stronger-than-expected operating profit, subject to broader market moves